MADRIGAL PHARMACEUTI (MDGL) insider trading activity (SEC Form 4). Over the trailing 90 days, MDGL insiders filed 0 purchases totalling $0 and 4 sales totalling $5.2M — net SELLING of $5.2M. Most recent filing: Jul 20, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | Sibold William John | Pres, CEO | S SaleOE | — | $547.30 | $1.4M | filing |
| Jun 1, 2026 | Soergel David | Chief Medical Officer | S Sale | — | $495.74 | $517K | filing |
| May 22, 2026 | Levy Richard S | Dir | S Sale | — | $515.44 | $2.9M | filing |
| May 18, 2026 | Soergel David | Chief Medical Officer | S Sale | — | $515.90 | $435K | filing |